We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLNO
12251
DELISTED
Soleno Therapeutics
SLNO
$165K ﹤0.01%
9,659
+5,466
+130% +$92.4K
SLS icon
12252
SELLAS Life Sciences
SLS
$2.58B
$165K ﹤0.01%
14,831
-9,568
-39% -$93.4K
SPRO icon
12253
Spero Therapeutics
SPRO
$71.6M
$165K ﹤0.01%
11,812
-8,268
-41% -$116K
UUUU icon
12254
Energy Fuels
UUUU
$3.77B
$165K ﹤0.01%
27,247
-337,759
-93% -$2.07M
CNCE
12255
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$165K ﹤0.01%
39,100
-26,100
-40% -$110K
CTAQU
12256
DELISTED
Carney Technology Acquisition Corp. II Units
CTAQU
$165K ﹤0.01%
16,530
-2,778
-14% -$27.9K
ATAQ.WS
12257
DELISTED
Altimar Acquisition Corp III Warrants
ATAQ.WS
$165K ﹤0.01%
+150,295
New +$148K
FBIO icon
12258
Fortress Biotech
FBIO
$97.7M
$164K ﹤0.01%
+3,062
New +$185K
GSIT icon
12259
GSI Technology
GSIT
$270M
$164K ﹤0.01%
29,259
+19,032
+186% +$117K
OPRA
12260
CALL
Opera Ltd
OPRA
$1.82B
$164K ﹤0.01%
16,000
+5,900
+58% +$62.6K
BHR
12261
CALL
Braemar Hotels & Resorts
BHR
$139M
$163K ﹤0.01%
26,200
-30,600
-54% -$189K
LAUR icon
12262
CALL
Laureate Education
LAUR
$5.18B
$163K ﹤0.01%
11,200
-26,200
-70% -$370K
SLDB icon
12263
PUT
Solid Biosciences
SLDB
$986M
$163K ﹤0.01%
2,973
-4,040
-58% -$267K
USAS
12264
Americas Gold and Silver
USAS
$1.77B
$163K ﹤0.01%
+42,876
New +$209K
GHL
12265
CALL
DELISTED
Greenhill & Co., Inc.
GHL
$163K ﹤0.01%
10,500
-16,800
-62% -$279K
BCACU
12266
DELISTED
Brookline Capital Acquisition Corp. Units
BCACU
$163K ﹤0.01%
+14,977
New +$161K
ETY icon
12267
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.33B
$162K ﹤0.01%
+11,487
New +$156K
LILA icon
12268
PUT
Liberty Latin America Class A
LILA
$1.69B
$162K ﹤0.01%
+17,222
New +$163K
TLGT
12269
DELISTED
Teligent, Inc
TLGT
$162K ﹤0.01%
+303,616
New +$173K
AXTI icon
12270
CALL
AXT Inc
AXTI
$5.35B
$161K ﹤0.01%
+14,700
New +$156K
IAG icon
12271
CALL
IAMGOLD
IAG
$10.4B
$161K ﹤0.01%
54,500
+33,300
+157% +$112K
MFG icon
12272
Mizuho Financial
MFG
$132B
$161K ﹤0.01%
56,683
-65,344
-54% -$195K
ACCO icon
12273
PUT
Acco Brands
ACCO
$401M
$160K ﹤0.01%
18,500
+2,600
+16% +$23.1K
CMPOW
12274
DELISTED
CompoSecure Inc Warrant
CMPOW
$160K ﹤0.01%
100,100
-51
-0.1% -$61
CHRN
12275
CALL
ChronoScale Holdings
CHRN
$3.04B
$160K ﹤0.01%
1,933
+680
+54% +$57.3K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.